home / stock / argx / argx quote
Last: | $472.87 |
---|---|
Change Percent: | -2.11% |
Open: | $470.72 |
Close: | $472.87 |
High: | $472.99 |
Low: | $460.0501 |
Volume: | 443,177 |
Last Trade Date Time: | 07/23/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$472.87 | $470.72 | $472.87 | $472.99 | $460.0501 | 443,177 | 07-23-2024 |
$461.01 | $474.9 | $461.01 | $476.198 | $457.42 | 369,787 | 07-22-2024 |
$471.32 | $466.1 | $471.32 | $471.8 | $466.1 | 615,682 | 07-19-2024 |
$466.56 | $459.79 | $466.56 | $469.885 | $459.62 | 476,141 | 07-18-2024 |
$463.41 | $465.59 | $463.41 | $471.11 | $457.49 | 536,786 | 07-17-2024 |
$471.795 | $468.01 | $471.795 | $475.26 | $460.58 | 470,659 | 07-16-2024 |
$461.94 | $470.05 | $461.94 | $470.88 | $460.91 | 249,329 | 07-15-2024 |
$466.42 | $466.12 | $466.42 | $475.33 | $465.6 | 352,416 | 07-12-2024 |
$461.72 | $465.67 | $461.72 | $471.46 | $461.08 | 245,519 | 07-11-2024 |
$467.23 | $461.81 | $467.23 | $467.7 | $459.04 | 332,690 | 07-10-2024 |
$457.68 | $444.21 | $457.68 | $459.7 | $442.745 | 384,174 | 07-09-2024 |
$436.42 | $439.03 | $436.42 | $439.03 | $432.96 | 222,954 | 07-08-2024 |
$435.84 | $439.43 | $435.84 | $442.36 | $433.05 | 145,247 | 07-05-2024 |
$435.29 | $437.04 | $435.29 | $438.55 | $433.35 | 197,750 | 07-04-2024 |
$435.29 | $437.04 | $435.29 | $438.55 | $433.35 | 197,750 | 07-03-2024 |
$435.49 | $437.14 | $435.49 | $444.49 | $429.27 | 287,008 | 07-02-2024 |
$434.22 | $430.45 | $434.22 | $438.12 | $428.97 | 329,974 | 07-01-2024 |
$430.04 | $432.69 | $430.04 | $439.12 | $428.76 | 536,806 | 06-28-2024 |
$444.94 | $445.88 | $444.94 | $448.93 | $443.45 | 258,298 | 06-27-2024 |
$445.88 | $453.235 | $445.88 | $456.6769 | $444.61 | 311,839 | 06-26-2024 |
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 08:00:17 ET Leland Gershell from Oppenheimer issued a price target of $546.00 for ARGX on 2024-07-23 07:02:00. The adjusted price target was set to $546.00. At the time of the announcement, ARGX was trading at $461.01. The overall price target consensus is at ...
July 18, 2024 Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that it will host a conference call and audio webcast on Thursday, Ju...
First and only NMPA-approved subcutaneous injectable FcRn blocker for gMG patients in China Consistent clinical benefit and safety profile of efgartigimod SC compared to IV demonstrated in Phase 3 ADAPT-SC study July 16, 2024 6:30am CET Amsterdam, the Netherlands— ...